Rigel Pharmaceuticals (RIGL) Gross Profit Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 29.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.27% |
| Dec 31, 2025 | 7.82% |
| Sep 30, 2025 | 42.93% |
| Jun 30, 2025 | 50.02% |
| Mar 31, 2025 | 43.33% |
| Dec 31, 2024 | 37.52% |
| Sep 30, 2024 | 30.26% |
| Jun 30, 2024 | 9.20% |
| Mar 31, 2024 | -30.15% |
| Dec 31, 2023 | 20.86% |
| Sep 30, 2023 | 13.76% |
| Jun 30, 2023 | 17.92% |
| Mar 31, 2023 | -23.30% |
| Dec 31, 2022 | 49.57% |
| Sep 30, 2022 | 2.55% |
| Jun 30, 2022 | 41.80% |
| Mar 31, 2022 | 9.90% |
| Dec 31, 2021 | -19.13% |
| Sep 30, 2021 | 64.61% |
| Jun 30, 2021 | 145.94% |